Yu-Wen Chen Selected Research

Analgesics (Analgesic Drugs)

4/2023	Naphazoline and oxymetazoline are superior to epinephrine in enhancing the cutaneous analgesia of lidocaine in rats.
8/2016	Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment.
5/2006	Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effect.
9/2004	The antinociceptive effect of buprenorphine and its long-acting ester buprenorphine benzoate in rats.
9/2003	The antinociceptive effect of nalbuphine and its long-acting esters in rats.
9/2003	The antinociceptive effect of a long-acting nalbuphine preparation in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Wen Chen Research Topics

Disease

23	Pain (Aches) 04/2023 - 09/2003
12	Neoplasms (Cancer) 07/2023 - 06/2005
9	Hyperalgesia 06/2022 - 09/2013
8	Hypersensitivity (Allergy) 06/2022 - 07/2013
5	Inflammation (Inflammations) 01/2022 - 07/2012
5	Neuroblastoma 01/2020 - 06/2010
5	Neuralgia (Stump Neuralgia) 01/2020 - 06/2012
4	Stroke (Strokes) 03/2024 - 12/2022
4	Fibrosis (Cirrhosis) 12/2023 - 04/2016
4	Peripheral Nerve Injuries 01/2017 - 09/2013
4	Rheumatoid Arthritis 01/2017 - 07/2012
4	Apnea 10/2012 - 01/2010
3	Infections 01/2023 - 05/2019
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 01/2013
3	Wounds and Injuries (Trauma) 01/2017 - 01/2004
3	Body Weight (Weight, Body) 07/2015 - 02/2013
3	Postoperative Pain 08/2014 - 07/2013
3	Lung Neoplasms (Lung Cancer) 11/2013 - 12/2007
3	Neoplasm Metastasis (Metastasis) 11/2013 - 12/2007
2	Neuroinflammatory Diseases 02/2024 - 01/2020
2	Cicatrix (Scar) 12/2023 - 02/2015
2	Heart Failure 09/2022 - 10/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2018 - 08/2015
2	Burns 01/2017 - 01/2004
2	Adenocarcinoma 03/2016 - 07/2013
2	Breast Neoplasms (Breast Cancer) 12/2014 - 07/2005
2	Infarction (Infarctions) 01/2014 - 03/2004
2	Nasopharyngeal Carcinoma 11/2012 - 09/2007
1	Demyelinating Diseases (Demyelinating Disease) 02/2024
1	Myocardial Infarction 12/2023
1	ST Elevation Myocardial Infarction 12/2023
1	Hyperglycemia 12/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Fatigue 01/2023
1	Schnitzler Syndrome 01/2023
1	Chronic Urticaria 01/2023
1	Fever (Fevers) 01/2023
1	Hemolysis 12/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2022
1	Thrombosis (Thrombus) 08/2022
1	Ischemic Stroke 08/2022

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 06/2022 - 06/2012
7	Interleukin-6 (Interleukin 6)IBA 02/2024 - 07/2013
6	Analgesics (Analgesic Drugs)IBA 04/2023 - 09/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2013
5	Substance PIBA 01/2019 - 07/2014
5	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 10/2015 - 01/2010
3	Phosphotransferases (Kinase)IBA 07/2023 - 07/2005
3	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 12/2007
3	diphenidol (Vontrol)FDA Link 03/2015 - 01/2012
2	Blood Glucose (Blood Sugar)IBA 12/2023 - 02/2013
2	Epinephrine (Adrenaline)FDA LinkGeneric 04/2023 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2023 - 08/2020
2	AntibodiesIBA 10/2021 - 11/2013
2	Interleukin-10 (Interleukin 10)IBA 12/2020 - 01/2017
2	erinacine AIBA 01/2020 - 01/2020
2	Phospholipases A2 (Phospholipase A2)IBA 04/2018 - 07/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 01/2013
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2017 - 07/2012
2	Insulin (Novolin)FDA Link 01/2017 - 07/2015
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 08/2016 - 03/2013
2	Heme Oxygenase-1IBA 08/2015 - 07/2012
2	Voltage-Gated Sodium ChannelsIBA 01/2015 - 08/2013
2	caramiphenIBA 01/2015 - 01/2012
2	quinolineIBA 01/2015 - 07/2011
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2014 - 07/2013
2	Thrombin FDA Link 10/2013 - 05/2013
2	carbetapentane (pentoxyverine)IBA 08/2013 - 01/2012
2	HSP72 Heat-Shock ProteinsIBA 10/2008 - 09/2007
1	CuprizoneIBA 02/2024
1	CopperIBA 02/2024
1	Chelating AgentsIBA 02/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2023
1	IntegrinsIBA 12/2023
1	MethyltransferasesIBA 07/2023
1	Tyrosine Kinase InhibitorsIBA 07/2023
1	Local AnestheticsIBA 04/2023
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 04/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	Histamine Antagonists (Antihistamines)IBA 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	Oseltamivir (Tamiflu)FDA Link 01/2023
1	tofacitinibIBA 01/2023
1	phosphorus pentoxideIBA 12/2022
1	AcetoneIBA 06/2022
1	polatuzumab vedotinIBA 02/2022

Therapy/Procedure

5	Ultrasonic Therapy 01/2019 - 01/2015
5	Therapeutics 07/2015 - 11/2012
4	Thoracotomy 06/2022 - 02/2018
3	Transcutaneous Electric Nerve Stimulation (TENS) 03/2015 - 07/2014
3	Intravenous Infusions 10/2012 - 01/2011
2	Oral Administration 02/2024 - 07/2011
2	Percutaneous Coronary Intervention 12/2023 - 09/2022
2	Activities of Daily Living (ADL) 01/2023 - 01/2023
2	Ligation 01/2020 - 09/2013
2	Aftercare (After-Treatment) 01/2018 - 07/2012
1	Stroke Rehabilitation 03/2024
1	Occupational Therapy (Therapy, Occupational) 12/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2022